OrthoPediatrics Q1 2022 Earnings Report
Key Takeaways
OrthoPediatrics Corp. reported a 9% increase in revenue for Q1 2022, reaching $23.4 million compared to $21.5 million in Q1 2021. The company's U.S. revenue increased by 8%, while international revenue grew by 13%. Trauma and Deformity revenue increased by 13%, Scoliosis revenue increased by 1%, and Sports Medicine/Other revenue decreased by 4%. The company has increased its full year 2022 revenue guidance to $122 million to $125 million.
Total revenue reached $23.4 million, a 9% increase year-over-year.
U.S. revenue increased by 8%, while international revenue grew by 13%.
Trauma and Deformity revenue increased by 13%, Scoliosis revenue increased by 1%.
Full year 2022 revenue guidance increased to $122 million to $125 million.
OrthoPediatrics
OrthoPediatrics
OrthoPediatrics Revenue by Segment
OrthoPediatrics Revenue by Geographic Location
Forward Guidance
For full year 2022, the Company now expects its full year revenue to be in the range of $122 million to $125 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income